Amgen appoints Katia Massaroni as Executive Medical Director for Italy and Greece

Katia Massaroni has been appointed as the new Executive Medical Director for Amgen Italia, effective September 1, 2026. In this capacity, she will oversee medical leadership for both the Italian and Greek markets.

Massaroni succeeds Alessandra Brescianini, who has transitioned to the role of Executive Medical Director for Thoracic Oncology and Biosimilars within Amgen’s Global Medical Oncology division.

A specialist in infectious diseases from Sapienza University of Rome, Massaroni brings extensive experience from both hospital settings and the pharmaceutical industry. Her previous professional background includes significant roles in Medical Affairs and Medical Operations at multinational companies such as Sanofi, Novartis, and Daiichi Sankyo.